Concepedia

Jens Würthner

JW

Statistics

Publications

17

Citations

969

H-Index

14

Active since

1995

Affiliations

Novartis (Switzerland)(Current)

Heinrich Heine University Düsseldorf

National Institutes of Health

GlaxoSmithKline (United Kingdom)

Johns Hopkins University

Jens Würthner is an author at Novartis (Switzerland) specializing in life sciences, cell biology, and medicine.

Publications per year

1995–2021

17

Publications

17

X-linked Inhibitor of Apoptosis Protein Functions as a Cofactor in Transforming Growth Factor-β Signaling

Stephanie Birkey Reffey, Jens Würthner, W. Tony Parks et al. · Journal of Biological Chemistry · 2001 · 144 citations · Full text

, , +17

Transforming Growth Factor-β Receptor-associated Protein 1 Is a Smad4 Chaperone

Jens Würthner, David B. Frank, Angelina Felici et al. · Journal of Biological Chemistry · 2001 · 91 citations · Full text

, , +15

Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial

Vincent Meininger, Pierre-François Pradat, Andrea M. Corse et al. · PLoS ONE · 2014 · 87 citations · Full text

, , +17

A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097

Sébastien Jeay, Swann Gaulis, Stéphane Ferretti et al. · eLife · 2015 · 87 citations · Full text

, , +17

Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53–MDM2 Inhibitor HDM201

Sébastien Jeay, Stéphane Ferretti, Philipp Holzer et al. · Cancer Research · 2018 · 87 citations · Full text

, , +17

1–5 of 17